Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCellyan Biotechnology Co Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q4 2025 | N/A | -$0.08 | N/A | N/A | $9.22 M |
| 09/30/2024 | Q2 2025 | N/A | $0.08 | N/A | N/A | $11.09 M |
| 03/31/2024 | Q4 2024 | N/A | $0.11 | N/A | N/A | $9.68 M |
| 09/30/2023 | Q2 2024 | N/A | $0.04 | N/A | N/A | $7.01 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cellyan Biotechnology Co Ltd. Earnings: FAQ's
The conference call for Cellyan Biotechnology Co Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Cellyan Biotechnology Co Ltd.'s latest earnings report can be read online.
Cellyan Biotechnology Co Ltd. (:HKPD) has a recorded annual revenue of $20.31 M.
Cellyan Biotechnology Co Ltd. (:HKPD) has a recorded net income of $-27,056.Cellyan Biotechnology Co Ltd. has generated $-0.0027 earnings per share over the last four quarters.
Cellyan Biotechnology Co Ltd. (:HKPD) has a price-to-earnings ratio of -199.93 and price/earnings-to-growth ratio is -2.